经尿道前列腺等离子剜除术和切除术治疗大体积前列腺增生症的比较

Comparison on the Curative Effects of Transurethral Plasmakinetic Enucleation of Prostate and Transurethral Plasmakinetic Resection of Prostate in the Treatment of Large Benign Prostatic Hyperplastia

目的比较经尿道前列腺等离子剜除术(TUPKEP)与经尿道前列腺等离子切除术(TUPKRP)治疗大体积前列腺增生症(LBPH)的疗效。方法选取我院2011年8月至2012年8月收治的100例的LBPH患者,分为TUPKEP组和TUPKRP组各50例。比较两组患者的疗效。结果两组患者均顺利完成手术。TUPKEP组的手术时间、术中出血量、继发性出血发生率、尿失禁发生率、留置尿管时间均优于TUPKRP组(P<0.05)。术后5年,TUPKEP组的IPSS评分、QOL评分、残余尿量、最大尿流率、前列腺增生症复发率、膀胱颈挛缩及前列腺癌发生率均优于TUPKRP组(P<0.05)。结论 TUPKEP治疗LBPH安全有效,恢复快,并发症少,远期疗效较好。

Objective To compare the curative effects of transurethral plasmakinetic enucleation of prostate （TUPKEP） and transurethral plasmakinetic resection of prostate （TUPKRP） in the treatment of large benign prostatic hyperplastia （LBPH）. Methods 100 cases of LBPH patients admitted to our hospital from August 2011 to August 2012 were selected and divided into TUPKEP group and TUPKRP group, with 50 cases in each group. The curative effects were compared between two groups. Results All patients completed the surgery successfully. The operation time, intraoperative blood loss, incidences of secondary bleeding and urinary incontinence and indwelling catheter time of TUPKEP group were significantly better than those of TUPKRP group （P 〈0.05）. 5 years after surgery, the IPSS score, QOL score, residual urine volume, maximum urinary flow rate, recurrence rate of BPH, and incidences of bladder neck contracture and prostatic cancer of TUPKEP group were significantly better than those of TUPKRP group （P 〈0.05）. Conclusions TUPKEP in the treatment of LBPH is safe and effective, with fast recovery, few complications and better long-term curative effect.